FUO-PETMamba:基于PET最大密度投影的人工智能框架用于不明原因发热病因分类的多中心验证
本研究开发并验证了FUO-PETMamba,一种基于PET最大密度投影(MIP)的弱监督人工智能框架,用于不明原因发热(FUO)的病因分类。多中心回顾性研究纳入681例FUO患者,开发队列355例,两个外部验证队列分别为195例和131例。模型在主要病因类别中表现出一定判别能力,校准和决策曲线分析提示潜在临床获益,阅读者研究显示AI辅助可提高初中级医师诊断准确性,但高级医师表现变化不一。
要点
- FUO-PETMamba基于PET MIP图像实现FUO病因分类,开发队列AUC为0.788–0.914。
- 外部验证队列AUC为0.701–0.927,性能跨队列和类别存在差异。
- AI辅助可提高初中级医师诊断准确性,高级医师变化不一。
核心结论
- FUO-PETMamba为FUO病因分类提供了基于PET MIP的AI辅助诊断支持框架,在多中心队列中表现可行,但需前瞻性验证。
研究设计与样本
- 回顾性多中心研究纳入681例接受基线[18F]FDG PET/CT的FUO患者,含开发队列355例和两个独立外部验证队列195例与131例。
- FUO-PETMamba为弱监督框架,分析由PET数据生成的PET MIP图像,评估采用判别力、校准和决策曲线分析,并开展阅读者研究。
主要发现
- 开发队列AUC:恶性肿瘤0.838、感染0.851、自身免疫病0.914、其他原因0.788。
- 外部验证队列1对应AUC分别为0.809、0.815、0.805、0.849。
- 外部验证队列2对应AUC分别为0.808、0.772、0.701、0.927。
- 校准和决策曲线分析提示主要病因类别潜在临床获益,但性能跨队列和类别存在差异。
- 阅读者研究中AI辅助提高初中级医师诊断准确性,高级医师表现变化不一。
关键数值与推荐
- 其他原因类别因病例数有限且阳性预测值和F1分数较低,应谨慎解读。
临床怎么用
- 该框架可作为FUO病因分类的AI辅助诊断支持工具,可能有助于减少经验依赖的诊断差异,但需前瞻性验证后应用。
局限性
- 其他原因类别病例数有限,阳性预测值和F1分数较低。
- 模型性能跨队列和类别存在差异。
- 高级医师在AI辅助下表现变化不一。
- 需要前瞻性验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Fever of unknown origin (FUO) remains diagnostically challenging because of heterogeneous causes, non-specific clinical manifestations, and overlapping imaging findings. We developed and validated FUO-PETMamba, a PET maximum-intensity-projection (MIP)-based artificial intelligence framework for AI-assisted aetiological classification of FUO. METHODS: This retrospective multicentre study included 681 patients with FUO who underwent baseline [18 F]FDG PET/CT, comprising one development cohort (n = 355) and two independent external validation cohorts (n = 195 and n = 131). FUO-PETMamba is a weakly supervised framework analysing PET MIP images generated from PET data. Model performance was assessed by discrimination, calibration, decision curve analysis (DCA). Attention-based visual explanations were generated using attention mechanisms and gradient-based activation mapping. A reader study assessed the potential assistive effect of model-predicted probabilities on physicians with different PET/CT experience. RESULTS: In the development cohort, FUO-PETMamba achieved AUCs of 0.838 for malignancy, 0.851 for infection, 0.914 for autoimmune disease, and 0.788 for miscellaneous causes. Corresponding AUCs were 0.809, 0.815, 0.805, and 0.849 in external validation cohort 1, and 0.808, 0.772, 0.701, and 0.927 in external validation cohort 2, respectively. Calibration and decision curve analysis suggested potential clinical benefit for the major aetiological categories, although performance varied across cohorts and classes. The miscellaneous category should be interpreted cautiously because of limited case numbers and low positive predictive value and F1 scores. In the reader study, AI assistance improved diagnostic accuracy for junior and intermediate physicians, whereas changes in senior-physician performance were variable. Post hoc attention-based visualisations highlighted clinically plausible hypermetabolic patterns and served as qualitative explanatory aids. CONCLUSIONS: FUO-PETMamba provides a PET MIP-based AI-assisted diagnostic support framework for aetiological classification of FUO across multicentre cohorts and may help reduce experience-dependent diagnostic variability after prospective validation.
引用
- Jiang C, Jiang Z, Teng Y, et al. FUO-PETMamba: a pet maximum-intensity-projection-based artificial intelligence framework for aetiological classification of fever of unknown origin with multicentre validation. Eur J Nucl Med Mol Imaging. 2026. PMID: 42435203. doi:10.1007/s00259-026-08061-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。